J. Goldman & Co LP 13D and 13G filings for Eagle Pharmaceuticals, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2025-08-14 8:08 pm Purchase | 2025-06-30 | 13G | Eagle Pharmaceuticals, Inc. EGRX | J. Goldman & Co LP | 667,108 5.100% | 667,108 (New Position) | Filing |